An interventional study of Cage fusion and Plate fusion in Cervical Vertebrae, Single and Degenerative Disease, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-04-17.
Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment
The use of plate in addition to autologous bone is better then stand alone cage fusion regarding fusion rate and segmental lordosis.
cage: MC+® cage plate: atlantis® plate
Seoul National University Hospital is the lead sponsor of 1,860 studies on the registry; 275 are open to participants now.
Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Cage filled with autologous bone
Procedure: Cage fusion
Plate augmentation after iliac bone graft
Procedure: Plate fusion
Randomized selection of surgery type
Also known as: Use of stand-alone Cage filled with autologous bone
Randomized selection of surgery type
Also known as: Use of Plate augmentation after autologous iliac bone graft
Fusion rate
The rate of interbody fusion at 2 years
Time frame: 2 years
Segmental angle
the segmental angle at the fused level
Time frame: 2 years
cervical lordosis
The cervical lordosis at 2 years
Time frame: 2 years
pain change
Visual analogue pain score
Time frame: 2 years
functional status change.
Neck disability index
Time frame: 2 years
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Hospital